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Antiarrhythmics, anticonvulsants and local anesthetics inhibit 
voltage‑gated sodium channels and reduce membrane excitability 
in neurons and muscle, making them useful in the management of 
cardiac arrhythmias, epilepsy and pain. These compounds, which 
are often termed singly in the literature as ‘local anesthetics’, have 
at least two inhibitory states: a resting inhibition that develops 
with intermittent stimulation and a higher affinity inhibition 
that arises upon repeated depolarization and likely involves the 
inactivated state of the channel. Although elucidating their mecha‑
nism of inhibition has been an active area of research for decades, 
many questions remain unanswered. Do these two inhibitory 
states share a common, but guarded or modulated receptor? Or 
do they represent different protonated states of the drugs, many 
of which have pKa’s close to physiological pH, thereby yielding a 
significant population of both charged and uncharged compound 
inside cells. Some mechanistic clues can be found by mutating 
conserved phenylalanine and tyrosine residues of the ‘local anes‑
thetic receptor’ in the channel’s inner vestibule. Mutations of 
these aromatic residues universally disrupt the mechanism of 
drug inhibition in numerous channel isoforms. For instance, non 
aromatic substitutions of Phe1579 (NaV1.4 numbering) in the pore 
lining S6 segment of domain four (DIVS6) can abolish inactivated 
state inhibition.1,2 The strict conservation of Phe1579 and other 
DIVS6 aromatic residues in all nine sodium channel isoforms led 
us to further dissect the role of this and other aromatic residues on 
local anesthetic inhibition. We recently employed subtly modified 
phenylalanine derivatives to better understand the role of these 
aromatics in the binding of local anesthetics and found a signifi‑
cant electrostatic interaction at one site, Phe1579, contributes 
to channel inhibition.3 What follows is a self guided tour of our 
motivation and experimental findings. 
Aromatic Side Chains Can Make Cation-π Interactions  
with Cationic Ligands
We set out to test the possibility that a cation-π interaction 
between cationic local anesthetics and the negative electrostatic 
potential on the face of the aromatic rings of phenylalanine or 
tyrosine contributes to the inhibitory mechanism. These residues 
are especially suited to bind organic cations because the energy 
of dehydrating the aromatic and the blocker are well matched,4 
thus allowing the blocker to get close to the face of the aromatic. 
Evidence for a cation-π interaction can also be insightful structurally 
as these interactions occur only when the cation is oriented toward 
the face, not the edge, of the aromatic ring.5 This prerequisite differs 
from the electrostatic interactions between the monopole charges 
of the side chains of glutamate or aspartate and lysine or arginine. 
In the latter case sterics plays less of a role. We have shown previ-
ously that cation-π interactions support the binding of cationic 
ligands to their aromatic lined receptors in GABA, acetylcholine and 
5HTchannels,6-9 and the extracellular block of voltage-gated sodium 
channels by tetrodotoxin (TTX) and Ca2+ and potassium channels 
by tetraethylammonium (TEA).0-2 In these examples, serial fluori-
nation of the aromatic side chain is used to empirically determine the 
energetic contribution of a cation-π interaction to binding. With this 
method, one, two or three fluorines are appended to the aromatic 
ring and serve to reduce the negative electrostatic potential on the 
face of the side chain in a step wise and predictable fashion while 
leaving the other chemical attributes of the side chain unaffected, 
including hydrophobicity.5,3 
A Single Cation-π Interaction Underlies Use-Dependence
Using the in vivo nonsense suppression method,4 we incorporated 
serially fluorinated phenylalanine residues at three aromatic sites in 
the NaV.4 skeletal muscle sodium channel. Mutation of the sites 
chosen, Phe574, Phe579 and Tyr586 was shown previously 
to affect channel inhibition by local anesthetics.2,5,6 The fluoro 
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Phe derivatives at these sites were well-tolerated and produced 
 channels with robust expression and normal voltage dependence of 
gating, substantially simplifying the interpretation of their effects 
on drug binding. Tonic block of channels by the local anesthetic 
and Class B antiarrhythmic compound lidocaine at 200 μM was 
assessed with 5 ms depolarizing pulses delivered at 20 s (0.05 Hz) 
intervals. Under these ‘resting’ conditions, fluorination at these 
sites had no effect on block indicating no electrostatic interaction 
between the aromatic ring and the drug. At higher frequencies, up 
to 20 Hz, fluorination disrupted use dependent inhibition at only 
one site, Phe579, indicating that a significant cation-π interaction 
between the drug and this aromatic underlies use dependent inhibi-
tion. The identical manipulation at the two other sites, Phe574 or 
Phe586, had no effect.
The Role of Charge
Might the lack of an electrostatic interaction in the resting state 
between the lidocaine and the aromatics be due, in part, to the 
protonation state of the drug? For instance, lidocaine could be in 
close proximity to the face of the tested aromatic, but in a neutral 
form during resting inhibition. Indeed, inhibition by the neutral 
local anesthetic benzocaine was similarly unaffected by fluorination, 
suggesting not only that these mutations primarily affect the elec-
trostatic properties of the aromatic side chain, but also that neutral 
blockers are oblivious to these manipulations. To answer the above 
question directly, we investigated block with QX 34, a drug with 
a similar structure as lidocaine except that it carries a permanent 
cationic charge on its quaternary ammonium moiety. For these 
experiments, we chose to tri fluorinate a single site, Phe579, both 
because of its central location in the local anesthetic receptor and 
because this manipulation slightly inverts the quadrupole moment of 
the aromatic ring.2 Surprisingly, even ablating the aromatic negative 
potential at Phe579 by tri-fluorination had no effect on the resting 
state blockade of QX 34, demonstrating that the blocker, while fully 
charged, does not have electrostatic access to Phe579 in the tonic 
state. Why then does Tyr586, which lies roughly on the same face 
of the S6 helix as Phe579, lack a measurable cation-π interaction in 
any state? One possibility is that the blocker might bind deep within 
the inner vestibule, perhaps plastered up against the selectivity filter, 
thus putting it out of reach from this distal S6 residue.
Putting It All Together
What new mechanistic insights can be drawn from this work? 
Previous experiments have suggested that the voltage dependence of 
the resting and stimulated states is similar, implying that the location 
of the charged compound in relation to the membrane electric field 
does not change when channels are stimulated.7 In terms of resting 
block, might the blocker be in the inner vestibule but in a position 
where it would not interact with Phe579? We believe that this possi-
bility is unlikely. Although the positive charge of the local anesthetic 
is concentrated near the ammonium group of the compound, the 
entire molecule carries a positive electrostatic charge (Fig. ). Thus, 
in the tight quarters of the inner vestibule any manipulation of the 
electrostatic potential on the face of the aromatic ring, which reaches 
~ 600 mV at a distance of 2 Å from the center of the aromatic ring,2 
should produce an effect if the aromatic is facing the inner vestibule. 
Our results therefore support the notion that the local anesthetic 
resides in the inner vestibule of the channel during resting or tonic 
blockade. Apparently at this stage the charged form of the drug is 
not a necessary requisite for use dependent inhibition, primarily 
because Phe579 is not facing the permeation pathway of the 
channel. Upon repeated stimulation, Phe579 presents its aromatic 
side chain towards the charged blocker (perhaps by rotation)8 with a 
movement we hypothesize to be concomitant with channel inactiva-
tion. We readily acknowledge that reorientation of Phe579 is only 
one of a number of protein rearrangements which likely underlie 
channel inactivation, a process that also involves the cytosolic III-IV 
linker and residues in other domains. Once bound, in part utilizing 
a cation-π interaction, the drug serves to hold Phe579 in the inner 
vestibule, stabilizing both the inactivated state of the channel and 
possibly, the activated voltage sensors in nearby domains.9 
Future Directions
Diversity of charge distribution on Class 1 anti‑arrhythmic 
drugs. Given the importance that cationic charge on the drug plays 
in the mechanism of use dependent inhibition, we investigated 
how it is distributed on three Class  drugs. For this analysis we 
chose quinidine, lidocaine and flecainide, each a representative of a 
Class  subcategory, A, B or C, respectively, and generated electro-
static potential distributions using ab initio quantum mechanical 
 calculations. The results of this analysis are seen in figure one 
(left-hand panels) and demonstrate that significant diversity of 
Figure 1. Diversity of electrostatic potential distribution and coordination 
chemistry with benzene amongst Class 1 anti-arrhythmic compounds. 
Analysis of quindine, lidocaine and flecainide are shown in panels (A–C), 
respectively. Left hand panels show the electrostatic potential calculated at the 
surface generated by a 2 Å spherical probe (gas phase, B3LYP/6-31+G**). 
Right hand panels show the optimized binding interactions with benzene 
(B3LYP/6-31G*). Quantum mechanical calculations used Jaguar (www.
Schrodinger.com). Scale bar shows the color coded range of potentials from 
0 (red) to +140 kcal/mol (blue). In each case, benzene interacts preferably 
with the more positively charged regions of the drug.
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charge distribution exists among these sodium channel inhibi-
tors, leading to divergent interaction stereochemistry with benzene 
(right-hand panels). In fact, although the entire surface of these 
compounds present a delocalized positive electrostatic potential, the 
more positively charged regions (blue) attract benzene more strongly. 
Future experiments will determine if these differences will translate 
into mechanistic heterogeneity that could be exploited in the design 
and discovery of novel inhibitors.
The Achilles heel of local anesthetics as clinical tools in the 
 management of membrane excitability is their lack of isoform speci-
ficity, owing mostly to the conserved nature of their receptor in the 
channel’s inner vestibule. Thus, the more we can learn about the 
details of the state dependent interactions between the drug and the 
channel, the closer we will be to designing drugs that can exploit the 
subtle differences in blocking mechanisms between isoforms. The 
 experiments described here put us one step closer to that distant goal. 
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